The tariff classification of Agomelatine (CAS-138112-76-2), imported in bulk form, from Germany
Issued March 26, 2007 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2924.29.6250
Headings: 2924
Product description
The subject product, Agomelatine, is an investigational new drug (IAD) being studied in a Phase III clinical trial (study start: December 2006) for its efficacy, safety and tolerability in the treatment of major depressive disorder.
CBP rationale
The applicable subheading for Agomelatine, imported in bulk form, will be 2924.29.6250, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: Other: Aromatic: Other: Drugs: Other: Other.
Full text
N008455 March 26, 2007 CLA-2-29:RR:NC:2:238 CATEGORY: Classification TARIFF NO.: 2924.29.6250 Mr. Joseph J. Chivini Austin Chemical Company, Inc. 1565 Barclay Boulevard Buffalo Grove, IL 60089 RE: The tariff classification of Agomelatine (CAS-138112-76-2), imported in bulk form, from Germany Dear Mr. Chivini: In your letter dated March 2, 2007, you requested a tariff classification ruling. The subject product, Agomelatine, is an investigational new drug (IAD) being studied in a Phase III clinical trial (study start: December 2006) for its efficacy, safety and tolerability in the treatment of major depressive disorder. The applicable subheading for Agomelatine, imported in bulk form, will be 2924.29.6250, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: Other: Aromatic: Other: Drugs: Other: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Neostigmine Methylsulfate (CAS No. 51-60-5) in bulk powder form, from India
The tariff classification of Lidocaine USP (CAS No. 137-58-6) and Lidocaine Hydrochloride Monohydrate (CAS No. 6108-05-0) in bulk powder form, from Spain
The tariff classification of Labetalol Hydrochloride (CAS No. 32780-64-6) in bulk powder form, from Italy
The tariff classification of Arformoterol Tartrate (CAS No. 200815-49-2) in bulk powder form, from Spain
The tariff classification of Solriamfetol (CAS No. 178429-62-4) in bulk powder form, from Italy
The tariff classification of Prilocaine (CAS No. 721-50-6) in bulk powder form, from Belgium
The tariff classification of Lidocaine Hydrochloride (CAS No. 73-78-9) in bulk powder form, from Brazil
The tariff classification of Prilocaine Hydrochloride (CAS No. 1786-81-8) from Brazil
The tariff classification of Embutramide (CAS 15687-14-6) in bulk form, from Italy
The tariff classification of Sacubitril Sodium (CAS 149690-05-1) in bulk form, from Taiwan
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →